NUCYNTA EXTENDED-RELEASE
KNIGHT THERAPEUTICS INC.
Quick answers
Is there a shortage of NUCYNTA EXTENDED-RELEASE in Canada?
No. There is no current shortage of NUCYNTA EXTENDED-RELEASE 50MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
Other Products
NUCYNTA IR
KNIGHT THERAPEUTICS INC.
APO-TAPENTADOL
APOTEX INC
NUCYNTA EXTENDED-RELEASE
KNIGHT THERAPEUTICS INC.
DIN
02415577
Strength
50MG
Dosage Form
Tablet (Extended-Release)
Route
Oral
Active Ingredient
TAPENTADOL (TAPENTADOL HYDROCHLORIDE)
See all TAPENTADOL (TAPENTADOL HYDROCHLORIDE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from KNIGHT THERAPEUTICS INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02468735
0.5MG · DIN 02381729
0.25MG · DIN 02381710
DIN 02332450
1G · DIN 02242980
DIN 02505223
400MG · DIN 02245828
30MG · DIN 02296152
DIN 02290308
25MG · DIN 01997602
20MG · DIN 01997572
5MG · DIN 01924516